Annual results announcement for the year ended 30 June 2026
Filed with HKEX · Stock code 8156 · · 152 pages · English
Summary by 6ix AI
The report highlights a significant decline in revenue and gross profit, primarily due to decreased demand in the pharmaceutical supply chain services sector. The company recorded a loss attributable to owners, which has increased compared to the previous year, reflecting challenges in the market environment.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Sinopharm Tech Holdings Limited on 6ix
Earlier from Sinopharm Tech
- Profit warning
- Announcement in relation to public float
- First quarterly results announcement for the three months ended 30 September 2021
- 2022 First quarterly report 2021/2022
Later from Sinopharm Tech
- Clarification announcement
- Annual report 2026
- Restoration of public float
- (Revised) monthly return of equity issuer on movements in securities for the month ended 31 January 2026
- (Revised) monthly return of equity issuer on movements in securities for the month ended 28 February 2026
Follow Sinopharm Tech into a list and get an email when it puts out news.
Follow Sinopharm Tech